UK markets open in 4 hours 17 minutes
NIKKEI 225
38,304.84 -530.26 (-1.37%) HANG SENG
18,558.20 +78.83 (+0.43%) CRUDE OIL
78.09 -0.29 (-0.37%) GOLD FUTURES
2,318.20 -6.00 (-0.26%) DOW
38,884.26 +31.99 (+0.08%) Bitcoin GBP
50,278.66 -749.49 (-1.47%)
Anebulo Pharmaceuticals, Inc. (ANEB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 80.39M |
| Enterprise value | 73.75M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 12.39 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -7.02 |
Trading information
Stock price history
| Beta (5Y monthly) | -1.00 |
| 52-week change 3 | 32.17% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 4.0500 |
| 52-week low 3 | 1.6200 |
| 50-day moving average 3 | 2.7560 |
| 200-day moving average 3 | 2.6191 |
Share statistics
| Avg vol (3-month) 3 | 5.89k |
| Avg vol (10-day) 3 | 4.99k |
| Shares outstanding 5 | 25.93M |
| Implied shares outstanding 6 | 25.93M |
| Float 8 | 3.9M |
| % held by insiders 1 | 65.38% |
| % held by institutions 1 | 28.15% |
| Shares short (15 Apr 2024) 4 | 20.12k |
| Short ratio (15 Apr 2024) 4 | 3.1 |
| Short % of float (15 Apr 2024) 4 | 0.48% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.08% |
| Shares short (prior month 15 Mar 2024) 4 | 4.58k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -54.65% |
| Return on equity (ttm) | -95.37% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -10.49M |
| Diluted EPS (ttm) | -0.4100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.64M |
| Total cash per share (mrq) | 0.26 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 6.72 |
| Book value per share (mrq) | 0.25 |
Cash flow statement
| Operating cash flow (ttm) | -9.58M |
| Levered free cash flow (ttm) | -5.77M |
© 2024 Yahoo. All rights reserved.